AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 374692
Drug: Parent-administered behavior
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-administered behavior checklist (regardless of group assignment)
Trial: 374692
Drug: Urinary excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary excretion of kryptopyrrole
Trial: 23132732
Drug: Standardized humor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized humor therapy group
Trial: 19856521
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of A/Vietnam/1194/2004 given 6 months apart
Trial: 19856521
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of A/Vietnam/1194/2004 given 21 days apart
Trial: 19856521
Drug: A/Indonesia/05/2005 booster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/Indonesia/05/2005 booster dose after one primary dose of A/Vietnam/1194/2004
Trial: 16740843
Drug: Iron-fortified rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified rice meal (approximately 15 mg of iron per day as ferric pyrophosphate)
Trial: 15634526
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose impulsion chemotherapy (HDIC)
Trial: 15634526
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose density chemotherapy (LDDC)
Trial: 8990427
Drug: 15-methyl prostaglandin
RxNorm normalized name: 15(S)-15-Methyl Prostaglandin F2α
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-methyl prostaglandin F2 alpha (250 micrograms, intramuscularly every 20 minutes, maximum three doses)
Trial: 8990427
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline, intramuscularly every 20 minutes, maximum three doses)
Trial: 3525273
Drug: Oral ketoconazole
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoconazole (400 mg for 5 days)
Trial: 3525273
Drug: Topical miconazole
RxNorm normalized name: miconazole Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical miconazole (1200 mg a single dose)
Trial: 21558457
Drug: Isoniazid 10
RxNorm normalized name: isoniazid 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoniazid 10 to 20 mg/kg/d orally
Trial: 12813116
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) plus SSRIs when indicated, initiated at a median of 17 days after MI for a median of 11 sessions over 6 months.
Trial: 12813116
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) plus SSRIs when indicated
Trial: 8497020
Drug: Imagery training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imagery training programme (visual and kinaesthetic imagery, internal and external perspectives), 6 weeks, bi-weekly sessions of 15 min each.
Trial: 8497020
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (competitive strategy unrelated to performance task), 6 weeks, bi-weekly sessions of 15 min each.
Trial: 3576125
Drug: Hourly aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hourly aspiration of gastric juice
Trial: 23866835
Drug: Granule group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granule group at 10 grams, three times daily (G10 group)
Trial: 23866835
Drug: Granule group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granule group at 20 grams, three times daily (G20 group)
Trial: 14586349
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (100 microg every 6 hours to a maximum of two doses)
Trial: 16019795
Drug: Low-dose group
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose group (1.5 g/day)
Trial: 16019795
Drug: High-dose group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose group (3.0 g/day)
Trial: 16019795
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (1.5 g/day and 3.0 g/day)
Trial: 10515023
Drug: Cold intraoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold intraoperative wound irrigation with a cold (18 C) 5% bacitracin solution for 5 minutes and postoperative wound cooling with a microtemperature pump for 24 hours.
Trial: 10515023
Drug: Standard postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard postoperative care without additional hypothermic therapy (control group).
Trial: 1837763
Drug: Short wave
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short wave therapy (460 MHz, 50‐60 W, for 8‐20 minutes)
Trial: 14748864
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (screening and treatment for depression by resident physicians)
Trial: 9213940
Drug: Taping and
RxNorm normalized name: Baza Cleanse and Protect Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taping and oral NSAID proglumetacine b.i.d. (26 patients)
Trial: 9213940
Drug: Taping and
RxNorm normalized name: Baza Cleanse and Protect Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taping and oral placebo b.i.d. (22 patients)
Trial: 8424422
Drug: Erythromycin 250
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 250 mg intravenously every 8 hours for nine doses
Trial: 23438483
Drug: Adalimumab weekly
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab weekly dosing
Trial: 23438483
Drug: Adalimumab every
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab every other week (eow) dosing
Trial: 21617556
Drug: Nerve block
RxNorm normalized name: Nerve Block Tray 22g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve block anesthesia at the wrist with 1% lidocaine followed by standard injection
Trial: 21617556
Drug: Standard injection
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard injection alone using 1-needle 2-syringe technique with 0.5 mL 1% lidocaine and 20 mg triamcinolone acetonide
Trial: 18433305
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and vitamin D supplementation (2000 mg calcium and 800 IU vitamin D/d)
Trial: 17202633
Drug: Miltefosine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miltefosine (2.5 mg/Kg/day, orally, o.d. or b.i.d., max 100 mg)
Trial: 17202633
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (1 mg/Kg/day, total 15 mg/Kg)
Trial: 12783417
Drug: Interferon beta1a
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta1a 22 microg subcutaneously once weekly
Trial: 10189772
Drug: Experimental form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental form of therapy of indeterminate benefit
Trial: 10189772
Drug: Randomized clinical
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized clinical trial of two therapies
Trial: 8610312
Drug: Increased common
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased common carotid intima-media thickness (CC-IMT)
Trial: 1928569
Drug: Levo-praziquantel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levo-praziquantel (20 mg/kg)
Trial: 6651596
Drug: 10% viscous
RxNorm normalized name: POVIDONE IODINE 10% VISCOUS GAUZE PAD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% viscous solution of phenylephrine hydrochloride
Trial: 6651596
Drug: 2.5% aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% aqueous solution of phenylephrine hydrochloride
Trial: 30678193
Drug: Tart cherry
RxNorm normalized name: Tart Cherry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tart cherry juice (480 mL daily for 12 weeks)
Trial: 23839181
Drug: Topical brimonidine
RxNorm normalized name: brimonidine Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical brimonidine tartrate gel 0.5%
Trial: 22379915
Drug: Ketoprofen combined
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen combined with intramuscular injection of trimeperidine
Trial: 16461817
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy (STD)
Trial: 11679455
Drug: Standard group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard group received insulin treatment
Trial: 11679455
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group received insulin if AC >70th percentile and/or FPG >120 mg/dl
Trial: 11679455
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (infants of women who did not receive insulin)
Trial: 9447368
Drug: Dihydralazine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydralazine (5 mg, repeated every 20 min up to 4 doses)
Trial: 9447368
Drug: Ketanserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (10 mg, repeated every 20 min up to 4 doses)
Trial: 8199822
Drug: Alkali citrate
RxNorm normalized name: alkali blite pollen extract
DrugBank: Suaeda moquinii pollen (DB10953)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alkali citrate therapy (group II, n = 25)
Trial: 29630549
Drug: Propolis (0.83
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propolis (0.83 g, n=30)
Trial: 24068048
Drug: Recovery of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery of intramuscular phosphocreatine concentration
Trial: 21417560
Drug: Continuous COC
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous COC (levonorgestrel [LNG] 90 μg/ethinylestradiol [EE] 20 μg)
Trial: 21417560
Drug: Cyclic COC
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic COC (LNG 100 μg/EE 20 μg, 21/7 days pattern)
Trial: 1486675
Drug: Intramuscular artemether
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular artemether plus oral mefloquine
Trial: 1486675
Drug: Intravenous artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous artesunate plus oral mefloquine
Trial: 1486675
Drug: Intravenous quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous quinine plus oral tetracycline
Trial: 7011353
Drug: Amoxycillin 250
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 250 mg or 500 mg, orally three times daily for seven days
Trial: 7011353
Drug: Ampicillin 250
RxNorm normalized name: ampicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 250 mg or 500 mg, orally three times daily for seven days
Trial: 7011353
Drug: Amoxycillin and
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin and Ampicillin (both doses)
Trial: 30859185
Drug: Ivermectin 100
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 100 or 200 μg/kg for PSAC; 200, 400 or 600 μg/kg for SAC
Trial: 23020829
Drug: Routine iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine iron group (n=2184) received 60 mg of ferrous sulphate plus 400 μg of folic acid daily
Trial: 23020829
Drug: Selective iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective iron group (n=2142) had screening and treatment for anaemia and a daily intake of 1 mg of folic acid
Trial: 20094773
Drug: erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: erlotinib 150 mg/day
Trial: 16805715
Drug: Rituximab added
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab added to chemotherapy
Trial: 16827869
Drug: TAS (tacrolimus/azathioprine/steroids)
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS (tacrolimus/azathioprine/steroids)
Trial: 16827869
Drug: TAS +
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS + B (tacrolimus/azathioprine/steroids/basiliximab)
Trial: 12810426
Drug: Epidural corticosteroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural corticosteroid injections (2 ml prednisolone acetate 50 mg)
Trial: 12810426
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline (2 ml)
Trial: 2194466
Drug: ibuprofen plus
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ibuprofen plus a rib belt
Trial: 7000292
Drug: Hormonal treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal treatment (stilboestrol and ethisterone)
Trial: 7000292
Drug: Inactive tablets
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive tablets (control group)
Trial: 28074635
Drug: Active arm
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active arm participants received pedometers and recorded step counts with physician monitoring and prescriptions; goal was a 3000 steps/day increase over 1 year.
Trial: 28074635
Drug: Active arm
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active arm participants (not treated with insulin)
Trial: 21365308
Drug: Resonance frequency
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Resonance frequency HRV biofeedback (10 weekly sessions)
Trial: 18164106
Drug: Co-administered quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administered quadrivalent HPV-6/11/16/18 L1 VLP and HBV vaccines
Trial: 12826431
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus platinum chemotherapy
Trial: 12826431
Drug: Conventional platinum-based
RxNorm normalized name: platinum
DrugBank: Platinum (DB12257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional platinum-based chemotherapy
Trial: 10921706
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (200 IU/kg)
Trial: 10921706
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (300 IU/kg heparin)
Trial: 8888725
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (5.1 g/day)
Trial: 1796780
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 1,600 micrograms
Trial: 10688033
Drug: HCG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCG treatment
Trial: 17470851
Drug: FLOX (Fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FLOX (Fluorouracil 500 mg/m2 IV bolus weekly for 6 weeks + Leucovorin 500 mg/m2 IV weekly for 6 weeks + Oxaliplatin 85 mg/m2 IV on weeks 1, 3, and 5 for three cycles)
Trial: 17470851
Drug: FULV (Fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FULV (Fluorouracil 500 mg/m2 IV bolus weekly for 6 weeks + Leucovorin 500 mg/m2 IV weekly for 6 weeks for three cycles)
Trial: 15472674
Drug: Bowel preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bowel preparation with 2 L of polyethylene glycol/electrolyte solution (Group A)
Trial: 15472674
Drug: Clear liquids
RxNorm normalized name: salicylic acid Medicated Liquid Soap [clear days ahead]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear liquids preparation (Group B)
Trial: 11159252
Drug: Epidural block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural block with 7 mL 1% lidocaine
Trial: 11159252
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of an identical volume of normal saline
Trial: 11159252
Drug: IV injection
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV injection of 1 mg/kg lidocaine
Trial: 9355788
Drug: Acetorphan (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetorphan (oral administration prior to cholera toxin)
Trial: 2529543
Drug: Acetorphan (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetorphan (oral administration)
Trial: 10710119
Drug: Fluvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (20 mg/day)
Trial: 3443128
Drug: Molsidomin 8
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomin 8 mg (slow release form)
Trial: 3443128
Drug: ISDN 40
RxNorm normalized name: ISDN 40 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISDN 40 mg (slow release form)
Trial: 20684724
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of RIX4414
Trial: 20684724
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of RIX4414
Trial: 20684724
Drug: RIX4414 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 (2 doses and 3 doses)
Trial: 10999014
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion (1.2 pmol/kg per min)
Trial: 8820253
Drug: Inhaled nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitroglycerin (NTG)
Trial: 8820253
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200 mu g MDI) after NTG
Trial: 8820253
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200 mu g MDI) after placebo
Trial: 8820253
Drug: FEV1 after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEV1 after 15 min post-treatment
Trial: 1996763
Drug: Lignocaine 10
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 10 mg
Trial: 29973970
Drug: Collagen (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen (2 ml of collagen MD Muscle)
Trial: 29973970
Drug: Lidocaine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (2 ml of 2% lidocaine without a vasoconstrictor)
Trial: 29973970
Drug: Saline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (2 ml of 0.9% NaCl)
Trial: 24094754
Drug: Intoxicating dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intoxicating dose of alcohol (.8 g/kg)
Trial: 20530650
Drug: No exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No exercise - no treatment (control group, n = 15)
Trial: 18826778
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (improved identification, diagnosis, and treatment of depression)
Trial: 8970342
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 micrograms twice a day)
Trial: 8571641
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of dipyridamole prior to PTCA
Trial: 8571641
Drug: Intracoronary dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary dipyridamole infusion during coronary angiography
Trial: 384574
Drug: Intra-arterial hepatic
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial hepatic artery infusion with 5-fluorouracil (5-FU)